Please enable Javascript to get a taste of that Hopium 👼

AFMD - Company Overview - Affimed N.V
Affimed N.V
NASDAQ: afmd

$3.84

USD

-$0.12

-3.03%

Prev Close

$3.96

Today's Open

$3.86

Volume

768.82K

Market Cap

377.42M

Day Range

3.78

range triangle

3.92

52W Range

3.59

range triangle

11.74

Overview

Affimed NV, a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Europe, and Germany. The company is headquartered in Heidelberg, Germany.

Read more
Current Price
15 min delay
Catalysts

There are currently no catalysts for AFMD. If there's something you'd like to see, feel free to reach out to us on discord.

Market Trend
SPDR S&P 500
Sector Trend
Healthcare
Sentiment
(beta)

Insufficient Data

Ratios
Valuation Ratios

EPS (TTM)

-0.49

P/E Ratio

0

Price to Sales

11.57

Price to Book

3.151

Profit Ratios

Profit Margin

-120.70%

EBITDA Margin

0.00%

Net Profit Margin

70.64%

ROA

-19.30%

Total Revenue

$40.85M

Net Profit

$28.86M

EV to EBITDA

0

EV to Revenue

5.81

Data source(s): Alpha Vantage